Results 21 to 30 of about 33,477 (277)

RNA‐seq and ATAC‐seq analysis of CD163+ macrophage‐induced progestin‐insensitive endometrial cancer cells

open access: yesCancer Medicine, 2023
Background Progestins are used as fertility‐sparing regimens for young patients with stage 1A endometrioid endometrial cancer (EEC) and atypical endometrial hyperplasia (AEH).
Lulu Wang   +6 more
doaj   +1 more source

Pengetahuan Pasangan Usia Subur Tentang Suntik Depo Progestin [PDF]

open access: yes, 2020
Fertile age couples are very easy to get offspring and therefore need to regulate fertility by having good knowledge in choosing contraception. The purpose of this study was to determine the study of the level of knowledge of fertile age couples about ...
Haslan, H. (Hasliana)   +3 more
core   +1 more source

Vitamin D and Mitosis Evaluation in Endometriosis: A Step toward Discovering the Connection?

open access: yesBiomedicines, 2023
(1) Background: The effects of serum vitamin D levels, the vitamin D receptor (VDR), and phosphohistone H3 (PHH3) in endometriosis were investigated in two cohorts of women with this pathology: those receiving hormonal treatment and those without ...
Daniela Roxana Matasariu   +9 more
doaj   +1 more source

Levonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta-analysis of 19 randomized controlled trials

open access: yesClinical and Experimental Obstetrics & Gynecology, 2020
Background: The aim of this meta-analysis was to compare levonorgestrel intrauterine system (LNG-IUS) with oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection.
Y. Sun   +8 more
doaj   +1 more source

Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States

open access: yesWomen's Health Reports, 2022
Objective: To assess interest in continued use of over-the-counter progestin-only pills among individuals who used them in a trial. Methods: From January 2020 to September 2021, we conducted a cross-sectional online survey with individuals who completed ...
Kate Grindlay   +5 more
doaj   +1 more source

Verteporfin reverses progestin resistance through YAP

open access: yes, 2023
Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP and TAZ (YAP/TAZ), downstream transcription coactivators of Hippo pathway,
Yao Liu   +9 more
core   +1 more source

Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study.

open access: yesPLoS ONE, 2017
ObjectiveTo estimate associations of progestin-only contraceptives with persistent pelvic girdle pain 18 months after delivery.MethodsProspective population based cohort study during the years 2003-2011. We included 20,493 women enrolled in the Norwegian
Elisabeth Krefting Bjelland   +6 more
doaj   +1 more source

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis

open access: yesFrontiers in Genetics, 2022
Objective: The aim of this study was to establish predictive models based on the molecular profiles of endometrial lesions, which might help identify progestin-insensitive endometrial atypical hyperplasia (EAH) or endometrioid endometrial cancer (EEC ...
Jia-Li Hu   +11 more
doaj   +1 more source

Progestins and cancer

open access: yesGynecological Endocrinology, 1999
The role of progestins in breast tissue is less well defined than in the endometrium. Although in vitro studies have shown that progestins induce a similar decrease in both estrogen and progesterone receptors and an increase in 17beta-estradiol dehydrogenase in the breast as in the endometrium, epidemiologic studies have suggested that progestins ...
R, Sitruk-Ware, G, Plu-Bureau
openaire   +2 more sources

DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma

open access: yesCancer Medicine, 2019
Progestin resistance limits the effectiveness of progestin therapy in endometrial carcinoma for patients who desire to preserve fertility. To investigate the molecular mechanism of progestin resistance in endometrial carcinoma, we performed microarray ...
Qing Zhou   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy